103
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

The potential toxic combination of grapefruit juice and sildenafil

&
Pages 334-337 | Received 15 Nov 2018, Accepted 01 Apr 2019, Published online: 23 Apr 2019
 

Abstract

Recent investigations have shown a potential growth in the sales of Grapefruit Juice (GFJ). GFJ contains furanocoumarins, which are potent mechanism-based inhibitors of CYP3A4. Sildenafil, used for erectile dysfunction is metabolized by CYP3A4, so the aim of our review was to understand the interaction between the ingestion of grapefruit juice and the treatment with sildenafil. In August 2018–March 2019 we performed a search in the electronic database PubMed (MEDLINE). The search terms were ‘sildenafil’ AND ‘grapefruit’; ‘sildenafil’ AND ‘naringin’. We searched for studies published without temporal limits, and in English, French, or Spanish. The literature search yielded 12 publications but the review included 2 articles. Studies were published in 2001 and 2002: 1 was settled in Germany, 1 in USA. In both the studies grapefruit led to an increase of peak concentration (Cmax) of sildenafil in plasma. One author showed that grapefruit juice increased the mean oral bioavailability of sildenafil by 23%. Concluding, the important growth in grapefruit juice consumption should be carefully considered by pharmacists and health professionals. Patients undergoing a treatment with sildenafil should be educated about potential adverse reactions.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.